Wang SC, Zhang L, Hortobagyi GN, Hung MC.Targeting Her2: recent developments and future directions for breast cancer patients. Semin Oncol. 2001;28(6 Suppl 18):21-29.
2.
Smyth PP.Thyroid disease and breast cancer. J Endocrinol Invest. 1993;16(5):396-401.
3.
Sevcikova L, Hunakova L, Chorvath B, et al.T-lymphocyte subsets (CD4/CD8 ratio) in breast cancer patients. Neoplasma. 1992;39(4):219-222.
4.
Ottery FD.Definition of standardized nutritional assessment and interventional pathways in outcome. Nutrition.1996;12(1 Suppl):S15-S19.
5.
Cheney CL, Mahloch J, Freeny P.Computerized tomography assessment of women with weight changes associated with adjuvant treatment for breast cancer. Am J Clin Nutr. 1997;66(1):141-146.
6.
Tisdale MJ.Wasting in cancer. J Nutr. 1999;129(1S Suppl):243S-246S.
7.
Crown J.Evolution in the treatment of advanced breast cancer. Semin Oncol. 1998;25(5 Suppl 12):12-17.
8.
Brugnatelli S, Riccardi A, Danova M, et al.Sequential docetaxel and vinorelbine for patients with advanced breast cancer previously treated with anthracyclines: a phase II study. Oncol Rep.2001;8(4):801-805.
9.
Kornek GV, Ulrich-Pur H, Penz M, et al.Treatment of advanced breast cancer with vinorelbine and docetaxel with or without human granulocyte colony-stimulating factor. J Clin Oncol. 2001;19(3):621-627.
10.
Perkins JB, Fields KK, Elfenbein GJ.Ifosfamide/carboplatin/etoposide chemotherapy for metastatic breast cancer with or without autologous hematopoietic stem cell transplantation: evaluation of dose-response relationships. Semin Oncol. 1995;22(Suppl 7):5-8.
11.
Tisdale MJ.Cancer anorexia and cachexia. Nutrition. 2001;17(5):438-442.
12.
al-Majid S, McCarthy DO.Cancer-induced fatigue and skeletal muscle wasting: the role of exercise. Biol Res Nurs. 2001;2(3): 186-197.
13.
Roubenoff R, Wilson IB.Effect of resistance training on self-reported physical functioning in HIV infection. Med Sci Sports Exerc. 2001;33(11):1811-1817.
14.
Roubenoff R.Acquired immunodeficiency syndrome wasting, functional performance, and quality of life. Am J Manag Care. 2000;6(9):1003-1016.
15.
Agin D, Gallagher D, Wang J, et al.Effects of whey protein and resistance exercise on body cell mass, muscle strength, and quality of life in women with HIV. AIDS. 2001;15(18):2431-2440.
16.
Quella SK, Loprinzi CL, Barton DL, et al.Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: a North Central Cancer Treatment Group Trial. J Clin Oncol. 2000;18(5):1068-1074.
17.
Allred CD, Allred KF, Ju YH, et al.Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner. Cancer Res. 2001;61(13):5045-5050.
18.
Nakagawa H, Yamamoto D, Kiyozuka Y, et al.Effects of genistein and synergistic action in combination with eicosapentaenoic acid on the growth of breast cancer cell lines. J Cancer Res Clin Oncol. 2000;126(8):448-454.
19.
Messina MJ, Loprinzi CL.Soy for breast cancer survivors: a critical review of the literature. J Nutr. 2001;131(11 Suppl):3095S-3108S.
20.
This P, De La Rochefordiere A, Clough K, et al.Phytoestrogens after breast cancer. Endocr Relat Cancer. 2001;8(2):129-134.
21.
Petilli M, Fiorelli G, Benvenuti S.Interactions between ipriflavone and the estrogen receptor. Calcif Tissue Int. 1995;56(2):160-165.
22.
Kuiper GG, Lemmen JG, Carlsson B, et al.Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology. 1998;139(10):4252-4263.
23.
Chen I, McDougal A, Wang F, et al.Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane. Carcinogenesis. 1998;19:1631-1639.
24.
Ge X, Yannai S, Rennert G, et al.3,3¢-diindolylmethane induces apoptosis in human cancer cells. Biochem Biophys Res Commun. 1996;228:153-158.
25.
Meng Q, Goldberg ID, Rosen EM, et al.Inhibitory effects of indole-3-carbinol on invasion and migration in human breast cancer cells. Breast Cancer Res Treat. 2000;63(2):147-152.
26.
Recchia F, Sica G, de Filippis S, et al.Interferon-beta, retinoids, and tamoxifen in the treatment of metastatic breast cancer: a phase II study. J Interferon Cytokine Res. 1995;15:605-610.
27.
Fraker LD, Halter SA, Forbes JT.Growth inhibition by retinol of a human breast carcinoma cell line in vitro and in athymic mice. Cancer Res. 1984;44:5757-5763.
28.
Charpentier A, Simmons-Menchaca M, Yu W, et al.RRR-alphatocopheryl succinate enhances TGF-beta 1, -beta 2, and -beta 3 and TGF-beta R-II expression by human MDA-MB-435 breast cancer cells. Nutr Cancer. 1996;26:237-250.
29.
Dai J, Ram PT, Yuan L, et al.Transcriptional repression of ROR alpha activity in human breast cancer cells by melatonin. Mol Cell Endocrinol. 2001;176(1-2):111-120.
30.
Eur J Cancer. 1996;32A;1340-1343.
31.
Liao S, Umekita Y, Guo J, et al.Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate. Cancer Lett. 1995;96(2):239-243.
